# Evaluating ActionADE in Reducing Adverse Drug Reactions

> **NCT04568668** · NA · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 3600 (estimated)

## Conditions studied

- Adverse Drug Event
- Adverse Drug Reaction

## Interventions

- **DEVICE:** ActionADE

## Key facts

- **NCT ID:** NCT04568668
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2022-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 3600 (ESTIMATED)
- **Last updated:** 2020-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04568668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04568668, "Evaluating ActionADE in Reducing Adverse Drug Reactions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04568668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*